Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer

• Principais autores: Silvia Nuzzo (Autor), Silvia Catuogno (Autor), Maria Capuozzo (Autor), Alfonso Fiorelli (Autor), Piotr Swiderski (Autor), Serena Boccella (Autor), Filomena de Nigris (Autor), Carla Lucia Esposito (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2019-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Non-small-cell lung cancer (NSCLC) accounts for 85%-90% of all cases of lung cancer that is the most deadly type of cancer. Despite advances in chemotherapy and radiotherapy, severe side effects and frequent drug resistance limit the success of the treatments, and the identification of new therapeut...